Active · per the CBE, 29 October 2026

Orexys

BE1017082018

Rechtspersoon Private limited company 1 establishment

Motstraat 72/8, 2800 Mechelen

Behind the company: Quentin Speeckaert, James Dehé.

Active for

1 year, 10 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 2 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Orexys from Mechelen, company number BE1017082018, closed financial year 2025 with a result of € 186,885 after tax. For that financial year Orexys recorded a gross margin of € 126,746 and equity of € 188,885. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.

What it is worth Healthy

€ 188,885

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 186,885

Profit after tax over the fiscal year.

Cash in the bank

€ 13,868

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 186,885.

Debts at end 2025

Bank debt ≈ 8 years to go

€ 6 million

€ 730,102 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 98,439

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,964

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

What happened to Orexys?

What happened at Orexys in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 186,885. Source: NBB ↗
  • New establishment in Mechelen. KBO
  • Quentin Speeckaert became a director. NBB
  • James Dehé became a director. NBB
  • Start of the company according to the CBE. KBO

Management

Quentin Speeckaert
James Dehé
Orexys

Behind Orexys are Quentin Speeckaert and James Dehé. It owns 85% of IMMUNO-CELL itself.

Directors

According to the 2025 annual accounts

Quentin Speeckaert

Director

Also active at: IMMUNO-CELL INTERNATIONAL, EXETERA

since 2024

James Dehé

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Motstraat 72/8

2800 Mechelen

2.372.146.876

Motstraat 72 box 8

2800 Mechelen

Active since 7 December 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1017.082.018
VAT number
BE 1017.082.018
Registered office
Motstraat 72/8, 2800 Mechelen
Names & denominations
Orexys
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
7 December 2024
Peppol
Active · Active since 17 Aug 2026

Frequently asked questions

What is the address of Orexys?
The registered office of Orexys is located at Motstraat 72/8, 2800 Mechelen.
Is Orexys still active?
Yes. According to the CBE (29 October 2026) Orexys is active, legal situation “Normale toestand”, started on 7 December 2024.
Is Orexys registered on Peppol?
Yes, Orexys is registered on the Peppol network with ID 0208:1017082018.
What is the enterprise number of Orexys?
The enterprise number of Orexys is BE1017082018.
When was Orexys founded?
Orexys was founded on 7 December 2024.
Who owns Orexys?
Behind Orexys are Quentin Speeckaert and James Dehé. It owns 85% of IMMUNO-CELL itself.